Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jenny Sprooten

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
International Review of Cell and Molecular Biology|March 7, 2020
Type I interferons and endoplasmic reticulum stress in health and diseaseJenny Sprooten, Abhishek D Garg
International Review of Cell and Molecular Biology|December 8, 2019
Type I interferons and dendritic cells in cancer immunotherapyJenny Sprooten, Patrizia Agostinis, Abhishek D Garg
Oncoimmunology|January 17, 2022
A first-in-class, non-invasive, immunodynamic biomarker approach for precision immuno-oncologyJenny Sprooten, An Coosemans, Abhishek D Garg
Molecular Oncology|January 21, 2026
Cotargeting TREM2 and IL2 pathways triggers multipronged anticancer immunityIsaure Vanmeerbeek, Jenny Sprooten, Abhishek D Garg
Genes and Immunity|June 3, 2021
Early memory differentiation and cell death resistance in T cells predicts melanoma response to sequential anti-CTLA4 and anti-PD1 immunotherapyIsaure Vanmeerbeek, Daniel M Borras, Jenny Sprooten, et al.
Immunological Reviews|November 8, 2023
The cell stress and immunity cycle in cancer: Toward next generation of cancer immunotherapyRaquel S Laureano, Isaure Vanmeerbeek, Jenny Sprooten, et al.
Oncoimmunology|October 25, 2019
Trial watch: dendritic cell vaccination for cancer immunotherapyJenny Sprooten, Jolien Ceusters, An Coosemans, et al.
Oncoimmunology|February 1, 2020
Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncologyIsaure Vanmeerbeek, Jenny Sprooten, Dirk De Ruysscher, et al.
Cells|December 11, 2022
The Interface of Tumour-Associated Macrophages with Dying Cancer Cells in Immuno-OncologyIsaure Vanmeerbeek, Jannes Govaerts, Raquel S Laureano, et al.
Cells|August 6, 2020
Necroptosis in Immuno-Oncology and Cancer ImmunotherapyJenny Sprooten, Pieter De Wijngaert, Isaure Vanmeerbeerk, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
International Review of Cell and Molecular Biology|March 7, 2020
Type I interferons and endoplasmic reticulum stress in health and diseaseJenny Sprooten, Abhishek D Garg
International Review of Cell and Molecular Biology|December 8, 2019
Type I interferons and dendritic cells in cancer immunotherapyJenny Sprooten, Patrizia Agostinis, Abhishek D Garg
Oncoimmunology|January 17, 2022
A first-in-class, non-invasive, immunodynamic biomarker approach for precision immuno-oncologyJenny Sprooten, An Coosemans, Abhishek D Garg
Molecular Oncology|January 21, 2026
Cotargeting TREM2 and IL2 pathways triggers multipronged anticancer immunityIsaure Vanmeerbeek, Jenny Sprooten, Abhishek D Garg
Genes and Immunity|June 3, 2021
Early memory differentiation and cell death resistance in T cells predicts melanoma response to sequential anti-CTLA4 and anti-PD1 immunotherapyIsaure Vanmeerbeek, Daniel M Borras, Jenny Sprooten, et al.
Immunological Reviews|November 8, 2023
The cell stress and immunity cycle in cancer: Toward next generation of cancer immunotherapyRaquel S Laureano, Isaure Vanmeerbeek, Jenny Sprooten, et al.
Oncoimmunology|October 25, 2019
Trial watch: dendritic cell vaccination for cancer immunotherapyJenny Sprooten, Jolien Ceusters, An Coosemans, et al.
Oncoimmunology|February 1, 2020
Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncologyIsaure Vanmeerbeek, Jenny Sprooten, Dirk De Ruysscher, et al.
Cells|December 11, 2022
The Interface of Tumour-Associated Macrophages with Dying Cancer Cells in Immuno-OncologyIsaure Vanmeerbeek, Jannes Govaerts, Raquel S Laureano, et al.
Cells|August 6, 2020
Necroptosis in Immuno-Oncology and Cancer ImmunotherapyJenny Sprooten, Pieter De Wijngaert, Isaure Vanmeerbeerk, et al.
Pageof 2